位置:首页 > 产品库 > BKM120(Buparlisib)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BKM120(Buparlisib)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BKM120(Buparlisib)图片
CAS NO:944396-07-0
包装:5mg, 10mg, 25mg

NVP-BKM120
Buparlisib

生物活性

BKM120 (NVP-BKM120, Buparlisib, AN2025)是一种选择性PI3K抑制,作用于p110α/β/δ/γ时,IC50分别为52 nM/166 nM/116 nM/262 nM,对VPS34, mTOR, DNAPK作用效果降低,对PI4Kβ几乎没有抑制活性。BKM120作用于解除PI3K调节的细胞系,包括A2780, U87MG, MCF7和DU145时,具有抗增殖活性,GI50为0.1-0.7 nM。 BKM120诱导多发性骨髓瘤细胞(ARP1, ARK, MM.1S, MM1.R和U266)凋亡,导致G1期细胞增多,S期细胞减少。BKM120诱导CD138+原代MM 细胞凋亡,且作用于CD138–基质细胞时毒性较低。


化学数据

分子量410.39
分子式C18H21F3N6O2
CAS号944396-07-0
纯度99.32%
溶解性(25°C)DMSO ≥80 mg/mL
储存和运输条件固体粉末: -20°C 冷藏长期储存
常温运输及临时存放

实验操作 来自于公开的文献,仅供相同实验参考(如实验材料、目的不同,请参考其他文献)

细胞实验
细胞系Rat1-myr-p110α, β, and δ and TSC1–/–-null MEFs cells
方法A total of 2 × 106 cells were seeded per 10-cm dish. Eighteen hours later, the medium was discarded and replaced with 10 mL of fresh medium containing the test items. Unless specified in the figure legend, the incubation period was 30 minutes. For agonist activation, cells were first starved for 18 hours in 9 mL of medium containing only 0.05% FBS. Then cells were pretreated for 30 minutes by addition of 1 mL of medium containing the test items and subsequently stimulated for 10 minutes with the agonist (final concentrations: 50 ng/mL for PDGF, 100 ng/mL for epidermal growth factor (EGF), 60 ng/mL interleukin (IL)-4, and 1 μmol/L anisomycin). Cells were washed twice, lysed, and processed by Western blot analysis as described
浓度0~10μM
处理时间30 min

动物实验
动物模型Orthotopic BT-474 tumors model with female Harlan nude (HsdNpa:Athymic Nude-nu) mice (8–10 weeks of age)
配制formulated in NMP/PEG300 (10/90, v/v)
剂量10 mg/kg
给药处理orally

不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

小鼠大鼠豚鼠仓鼠
重量 (kg)0.020.151.80.40.0810
体表面积 (m2)0.0070.0250.150.050.020.5
Km系数36128520
动物 A (mg/kg) = 动物 B (mg/kg) × 动物 B的Km系数
动物 A的Km系数

例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。


储备液配制

以下数据基于产品分子量,对于特殊产品,请参照COA中的储备液配制条件和说明进行操作。

Concentration / Solvent Volume / Mass1 mg5 mg10 mg
1 mM2.4367 mL12.1835 mL24.3671 mL
5 mM0.4873 mL2.4367 mL4.8734 mL
10 mM0.2437 mL1.2184 mL2.4367 mL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024